An autoimmune disease results from a much more aggressive immune response that gets pointed against the body itself, causing it to start to attack its own tissues. An immune imbalance can influence multiple parts of the body, including our joints, skin, kidneys, nervous system, digestive tract, blood vessels and muscles. Some of the most prevalent autoimmune diseases include systematic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, Crohn’s disease, ulcerative colitis or psoriasis and other inflammatory chronic disorders.
Many people with autoimmune diseases search for other supportive forms of care beyond usual care, because these conditions are complicated and often chronic. An increasingly appealing area is the use of UC-MSCs as stem cell therapy – namely using stromal cells derived from umbilical cords. Research has been done exploring the role of UC-MSCs in immune modulation and control of inflammation and tissue-repair support.
What Are UC-MSCs?
Umbilical Cord-Derived Mesenchymal Stem/Stromal Cells (UC-MSCs) are mesenchymal stem stromal cells that are isolated from donated umbilical cord tissue following a healthy birth. They are widely investigated in regenerative medicine between their ability to release biologically active signals like growth factors, cytokines, extracellular vesicles and other cell-communication mediators.
In autoimmune disease, UC-MSCs are primarily used to regulate the immune response rather than replacing lost tissue de novo. Rather, their potential as treatment substances lies in their communication capabilities with the immune system. Although the underlying mechanisms are being unveiled, UC-MSCs might help modulate immune cells, inhibit excessive inflammatory activity and sustain a balanced microenvironment through paracrine interactions.
This is why stem cell therapy using UC-MSCs for the treatment of an autoimmune disease such as CFS is frequently referred to more as a supportive regenerative treatment, than a cure.
Immune Modulation
Immune dysregulation is a highlight feature in autoimmunity. The immune system can become hyperactive, fighting against itself by attacking normal tissues while introducing continuous inflammatory processes. The interaction of UC-MSCs with immune cells (T cells, B cells, macrophages and dendritic cells) may play an important role in maintaining the balance of the immune system.
Which just means that suppressing the immune system as a whole is not the goal, but rather directing it towards balance. UC-MSCs relate this immune-modulating effect is one of the major attraction points to use UC-MSC in autoimmune and inflamed conditions.
Anti-Inflammatory Signaling
This continuous inflammations is one of is imiversus major causes of many autoinmuncy diseases; In the case of lupus, inflammation can involve skin, joints, kidneys and blood vessels. It could harm the joints in rheumatoid arthritis. In inflammatory bowel disease, it can damage the lining of intestine.
UC-MSCs may secrete factors that exert anti-inflammatory responses to dampen overstimulated inflammatory actvitiy. Stem cell therapy using UC-MSCs may assist certain individuals to better deal with the stress of inflammation in their bodies by providing a less inflammatory milieu.
Support for Tissue-Repair Environment
Some autoimmune diseases cause chronic cycles of inflammation which may lead to the damage and injury. Ultimately, this may cause discomfort, stiffness, fatigue and decreased range of motion or pressure on the organs and its capacity to perform daily tasks.
UC-MSCs can secrete growth factors and extracellular vesicles that may facilitate tissue-repair signaling. These signals could possibly establish a more favorable microenvironment surrounding the diseased tissues. Now, this is not to suggest that the body can just undo all the damage from autoimmune or anything like that but it may provide a much better biological environment for healing and repair.
TREATMENT OF AUTOIMMUNE DISEASE WITH UC-MSCs
Stem Cell Therapy of Autoimmune Disease With UC-MSCs:
Potential Advantages
Supporting immune balance
Helping regulate inflammatory activity
Supporting tissue-repair signaling
Promoting a healthier internal environment
Supporting general well-being and quality of life
In conjunction with conventional treatment for autoimmune disease
This can depend on the initial diagnosis of each patient, their severity of disease, the number and type of organs involved if any prior therapies were used, both general and local inflammatory status and lifestyle related aspects like body mass index (BMI), history of endocrine diseases and overall health condition.
Systemic Lupus Erythematosus
Lupus is a complex and multi-system autoimmune disorder with symptoms that can affect your skin, joints, kidneys, blood and nervous system. UC-MSCs are also considered for immune regulation and inflammation support in certain patients (with systemic immune activity).
Rheumatoid Arthritis
Patients with rheumatoid arthritis have ongoing inflammation of the joints and tissue is damaged by immune activity. UC-MSCs may beneficially contribute to inflammatory homeostasis and tissue-repair signaling in the arthritic joint microenvironment.
Multiple Sclerosis
Multiple sclerosis is a type of autoimmune disease that impacts the initiation system. UC-MSCs have received attention for their possible signaling capabilities in many aspects such as immunomodulatory and neuro-supportive signaling.
Inflammatory Bowel Disease
Both Crohn’s disease and ulcerative colitis are diseases that cause chronic inflammation of the digestive tract. UC-MSCs could provide immunoregulatory features in inflammatory bowel diseases and act as a source of therapeutic signals by promoting immune balance and tissue-repair signaling in specific inflammatory bowel situations.
Figure 1: Proposed Supportive Roles of UC-MSCs in Autoimmune Disease Management
Who Can Be Candidate for Stem Cell Therapy (UC-MSCs)
UC-MSCs appear to be a viable option for internationally recognized standard therapeutic applications, whereas stem cell therapy may not be appropriate due to the immunosuppressive nature of UC-MSCs (when given intravenously) and how they might interact with different autoimmune disease pathways. The classification may be appropriate for patients suffering from chronic inflammation, flare-associated pain or fatigue, impaired quality of life or symptomatic persistency despite conventional therapy.
Proper medical evaluation should be the first step you do before beginning treatment. The doctor can check some blood tests, autoimmune markers, inflammatory markers, kidney and liver function work, medication history is also important for him to know if you have an infection and how has developed his health condition type of organ involvement.
Conclusion
Stem cell therapy with UC-MSCs for autoimmune disease is an attractive novel application of regenerative medicine due to its potential to promote immune balance, convey anti-inflammatory signaling, and support multipotent-stem-cell mediated tissue-repair. UC-MSCs may act via paracrine signaling with immune system through cytokines, growth factors and extracellular vesicles.
For autoimmune diseases like lupus, rheumatoid arthritis, multiple sclerosis, Crohn’s disease, ulcerative colitis and other immune-related disorders UC-MSCs may be able to provide supportive potential for selected patients. But realistic expectations, careful screening, and ongoing standard medical care are still needed.